Factors associated with stellate ganglion block success in recurrent ventricular arrhythmias.
Stellate ganglion block
Ventricular fibrillation
Ventricular tachycardia
Journal
ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191
Informations de publication
Date de publication:
10 Sep 2024
10 Sep 2024
Historique:
revised:
19
08
2024
received:
14
04
2024
accepted:
24
08
2024
medline:
10
9
2024
pubmed:
10
9
2024
entrez:
10
9
2024
Statut:
aheadofprint
Résumé
One treatment option for refractory ventricular arrythmias is stellate ganglion block (SGB). We examined differences in SGB success by patient and arrhythmia characteristics and predictors of successful SGB. This was a multicenter analysis of patients treated for refractory ventricular arrythmias in the Czech Republic and the United States. The primary outcome was absence of ventricular arrythmias at 24 h post SGB. SGB effectiveness was examined according to aetiology of cardiomyopathy, arrhythmia type, laterality of SGB, presence of inotropes, and presence of mechanical circulatory support. Binary logistic regression was used to examine variables associated with the primary outcome. In total there were 117 patients with refractory ventricular arrythmias treated with SGB. Overall, the mean age was 63.5 ± 11.0 years, majority of patients were male (94.0%), White (87.2%), and had an implantable cardioverter defibrillator in situ (70.1%). There were no differences in efficacy of SGB based on aetiology of cardiomyopathy (P = 0.623), arrhythmia type (0.852), laterality of block (P = 0.131), and presence of inotropes (P = 0.083). Multivariable analysis demonstrated that increased age was associated with decreased odds of SGB success (odds ratio: 0.96, confidence interval: 0.92-0.99, P = 0.039) whereas increased left ventricular ejection fraction trended towards increased odds of SGB success (odds ratio: 1.05, confidence interval: 0.995-1.11, P = 0.077). In this multicentre experience, SGB was similarly effective despite the aetiology of cardiomyopathy, type of arrhythmia, laterality, and inotropic or mechanical support. SGB was less effective for the suppression of ventricular arrythmias at 24 h for the elderly.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Author(s). ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
Références
Franciosi S, Perry FKG, Roston TM, Armstrong KR, Claydon VE, Sanatani S. The role of the autonomic nervous system in arrhythmias and sudden cardiac death. Auton Neurosci 2017;205:1‐11. doi:10.1016/j.autneu.2017.03.005
Fudim M, Boortz‐Marx R, Patel CB, Sun AY, Piccini JP. Autonomic modulation for the treatment of ventricular arrhythmias: therapeutic use of percutaneous stellate ganglion blocks. J Cardiovasc Electrophysiol 2017;28:446‐449. doi:10.1111/jce.13152
Bradfield JS, Ajijola OA, Vaseghi M, Shivkumar K. Mechanisms and management of refractory ventricular arrhythmias in the age of autonomic modulation. Heart Rhythm 2018;15:1252‐1260. doi:10.1016/j.hrthm.2018.02.015
Chouairi F, Rajkumar K, Benak A, Qadri Y, Piccini JP, Mathew J, et al. A multicenter study of stellate ganglion block as a temporizing treatment for refractory ventricular arrhythmias. JACC Clin Electrophysiol 2024;10:750‐758. doi:10.1016/j.jacep.2023.12.012
Fudim M, Qadri YJ, Waldron NH, Boortz‐Marx RL, Ganesh A, Patel CB, et al. Stellate ganglion blockade for the treatment of refractory ventricular arrhythmias. JACC Clin Electrophysiol 2020;6:562‐571. doi:10.1016/j.jacep.2019.12.017
Ganesh A, Qadri YJ, Boortz‐Marx RL, Al‐Khatib SM, Harpole DH Jr, Katz JN, et al. Stellate ganglion blockade: an intervention for the management of ventricular arrhythmias. Curr Hypertens Rep 2020;22:100.
Tavazzi G, Dammassa V, Colombo CNJ, Arbustini E, Castelein T, Balik M, et al. Mechanical circulatory support in ventricular arrhythmias. Front Cardiovasc Med 2022;9:987008. doi:10.3389/fcvm.2022.987008
Rehorn MR, Black‐Maier E, Loungani R, Sen S, Sun AY, Friedman DJ, et al. Electrical storm in patients with left ventricular assist devices: risk factors, incidence, and impact on survival. Heart Rhythm 2021;18:1263‐1271. doi:10.1016/j.hrthm.2021.03.047
Harding JD, Piacentino V 3rd, Rothman S, Chambers S, Jessup M, Margulies KB. Prolonged repolarization after ventricular assist device support is associated with arrhythmias in humans with congestive heart failure. J Card Fail 2005;11:227‐232. doi:10.1016/j.cardfail.2004.08.158
Burzotta F, Trani C, Doshi SN, Townend J, van Geuns RJ, Hunziker P, et al. Impella ventricular support in clinical practice: collaborative viewpoint from a European expert user group. Int J Cardiol 2015;201:684‐691. doi:10.1016/j.ijcard.2015.07.065
Rengo G, Pagano G, Vitale DF, Formisano R, Komici K, Petraglia L, et al. Impact of aging on cardiac sympathetic innervation measured by (123)I‐mIBG imaging in patients with systolic heart failure. Eur J Nucl Med Mol Imaging 2016;43:2392‐2400. doi:10.1007/s00259‐016‐3432‐3
de Lucia C, Piedepalumbo M, Paolisso G, Koch WJ. Sympathetic nervous system in age‐related cardiovascular dysfunction: pathophysiology and therapeutic perspective. Int J Biochem Cell Biol 2019;108:29‐33. doi:10.1016/j.biocel.2019.01.004
Weidner K, Schupp T, Rusnak J, El‐Battrawy I, Ansari U, Hoppner J, et al. Impact of age on the prognosis of patients with ventricular tachyarrhythmias and aborted cardiac arrest. Z Gerontol Geriatr 2023;56:484‐491. doi:10.1007/s00391‐022‐02131‐6
Koplan BA, Stevenson WG. Ventricular tachycardia and sudden cardiac death. Mayo Clin Proc 2009;84:289‐297. doi:10.4065/84.3.289
Zekios KC, Mouchtouri ET, Lekkas P, Nikas DN, Kolettis TM. Sympathetic activation and arrhythmogenesis after myocardial infarction: where do we stand? J Cardiovasc Dev Dis 2021;8:57. doi:10.3390/jcdd8050057